Pfizer Goes On Offense With Celebrex: TV Ads, Study Proposal Stress Safety
Executive Summary
Pfizer is positioning Celebrex as the safest choice for pain therapy in its communications to physicians and consumers in the wake of the withdrawal of Merck's Vioxx